D-0101-2018 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0101-2018 was initiated by Zydus Pharmaceuticals USA Inc on Nov 20, 2017 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets The recall status is terminated (terminated Sep 1, 2020). Affected quantity: 19812 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 6, 2017
Initiation Date
Nov 20, 2017
Termination Date
Sep 1, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19812 bottles

Product description

Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC 68382-099-10) count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534

Reason for recall

Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets

Distribution pattern

Nationwide

Code information

a) Z701308, b) Z701309, c) Z701310 exp April 2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0101-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0101-2018. Report a data issue: hello@regdatalab.com.